Magnetic Resonance Imaging (MRI) research seeks to establish fast, sensitive, repeatable, and quantitative methods. The reduction of MRI acquisition times is important for patients who have significant disease, such as glioblastoma multiforme (GBM), and therewith difficulties with lengthy scan sessions. Magnetic Resonance Fingerprinting (MRF) is a method that can enable fast quantitative T1 and T2 mapping by exploiting transient signals caused by the variation of pseudorandom sequence parameters. This work demonstrates the feasibility of MRF in three patients with GBM, showing two before and after gadolinium contrast.
This abstract and the presentation materials are available to members only; a login is required.